AV
IDXX icon

ASR Vermogensbeheer’s Idexx Laboratories IDXX Stock Holding History

ASR Vermogensbeheer’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.63M Buy
14,497
+7,795
+116% +$4.37M 0.08% 231
2026
Q1 		$3.77M Buy
6,702
+110
+2% +$70.5K 0.04% 285
2025
Q4 		$4.46M Buy
6,592
+2,946
+81% +$2.01M 0.05% 266
2025
Q3 		$2.33M Buy
3,646
+13
+0.4% +$7.89K 0.03% 346
2025
Q2 		$1.95M Sell
3,633
-8
-0.2% -$3.83K 0.03% 367
2025
Q1 		$1.53M Buy
+3,641
New +$1.58M 0.02% 371

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

ASR Vermogensbeheer's IDXX Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Idexx Laboratories (IDXX) stake by 116% in Q2 2026, buying an estimated $4.37M and bringing the position to 14,497 shares worth $7.63M. The position accounts for 0.08% of the portfolio, ranked #231.

ASR Vermogensbeheer first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • ASR Vermogensbeheer held 14,497 shares of Idexx Laboratories worth $7.63M as of Q2 2026.
  • ASR Vermogensbeheer bought 7,795 Idexx Laboratories shares in Q2 2026, an estimated $4.37M.
  • Idexx Laboratories made up 0.08% of ASR Vermogensbeheer's portfolio in Q2 2026, its #231 holding.
  • ASR Vermogensbeheer first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.